PONTIAC (NT-proBNP Selected PreventiOn of cardiac events in a populaTion of dIabetic patients without A history of Cardiac disease) A Prospective Randomized …

…, G Strunk, H Brath, C Francesconi, C Adlbrecht… - Journal of the American …, 2013 - jacc.org
Objectives : The study sought to assess the primary preventive effect of neurohumoral
therapy in high-risk diabetic patients selected by N-terminal pro–B-type natriuretic peptide (NT-…

Exercise training improves vascular endothelial function in patients with type 1 diabetes

…, C Francesconi, HP Seit, M Francesconi… - Diabetes …, 2002 - Am Diabetes Assoc
OBJECTIVE—Impaired endothelial function of resistance and conduit arteries can be
detected in patients with type 1 diabetes. We studied whether a persistent improvement of …

Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double …

…, H Afanasieva, C Francesconi… - The Lancet …, 2023 - thelancet.com
… Although baseline C-reactive protein concentrations were used to evaluate potential
differences in inflammatory burden between groups, change from baseline in C-reactive protein …

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3 …

…, M De Maeyer, CFDM Francesconi… - The lancet …, 2022 - thelancet.com
Background Etrolizumab is a gut-targeted, anti-β7 integrin, monoclonal antibody. In an earlier
phase 2 induction study, etrolizumab significantly improved clinical remission compared …

Ferrara intrastromal corneal ring segments for severe keratoconus

D Miranda, M Sartori, C Francesconi… - Journal of Refractive …, 2003 - journals.healio.com
PURPOSE: lntrastromal Ferrara ring segments were inserted in eyes with severe keratoconus
to evaluate safety and efficacy of this procedure. METHODS: lntrastromal Ferrara ring …

Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial

…, J Torre-Cisneros, CFDM Francesconi… - The Lancet infectious …, 2021 - thelancet.com
C difficile vaccine candidate group (n=6201) or to the placebo group (n=3101). 6173 (99·5%)
participants in the C … In the C difficile vaccine candidate group, 34 C difficile infections were …

PET imaging with 89Zr: from radiochemistry to the clinic

MA Deri, BM Zeglis, LC Francesconi… - Nuclear medicine and …, 2013 - Elsevier
The advent of antibody-based cancer therapeutics has led to the concomitant rise in the
development of companion diagnostics for these therapies, particularly nuclear imaging agents. …

Comparison between handgrip strength, subjective global assessment, anthropometry, and biochemical markers in assessing nutritional status of patients with …

…, MR Alvares-da-Silva, CFM Francesconi - Digestive diseases and …, 2010 - Springer
… laboratory evaluation [22] (erythrocyte sedimentation rate, C-reactive … remission criteria as
indicated by C-reactive protein measurements. … Carlos Fernando Magalhães Francesconi

Low level laser therapy in primary Raynaud's phenomenon--results of a placebo controlled, double blind intervention study.

M Hirschl, R Katzenschlager, C Francesconi… - The Journal of …, 2004 - jrheum.org
… Oscillograms were inspected for indications of spasm both spontaneously after warm (5
min in water at 37C) and cold provocation (5 min in water at 12C) and 1, 3, 5, 7, 10, 12, 15, 17, …

α-emitters for radiotherapy: from basic radiochemistry to clinical studies—part 1

S Poty, LC Francesconi, MR McDevitt… - Journal of Nuclear …, 2018 - Soc Nuclear Med
With a short particle range and high linear energy transfer, α-emitting radionuclides demonstrate
high cell-killing efficiencies. Even with the existence of numerous radionuclides that …